American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer

Authors

  • Dr. Debbie Saslow PhD,

    1. Saslow is Director, Breast and Gynecologic Cancer, American Cancer Society, Atlanta, GA
    Search for more papers by this author
  • Dr. Carolyn D. Runowicz MD,

    1. Runowicz is Vice Chairman, Department of Obstetrics and Gynecology, St. Lukes-Roosevelt Hospital Center, New York, NY
    Search for more papers by this author
  • Dr. Diane Solomon MD,

    1. Solomon is Project Officer, ASCUS/LSIL Triage Study, National Cancer Institute, Rockville, MD
    Search for more papers by this author
  • Dr. Anna-Barbara Moscicki MD,

    1. Moscicki is Director, Teen Colposcopy Clinic and Associate Director, Division of Adolescent Medicine, University of California, San Francisco, CA
    Search for more papers by this author
  • Dr. Robert A. Smith PhD,

    1. Smith is Director of Cancer Screening, American Cancer Society, Atlanta, GA
    Search for more papers by this author
  • Dr. Harmon J. Eyre MD,

    1. Eyre is Chief Medical Officer and Executive Vice President for Research and Cancer Control, American Cancer Society, Atlanta, GA, and Editor in Chief of CA
    Search for more papers by this author
  • Dr. Carmel Cohen MD

    1. Cohen is Professor and Director, Division of Gynecologic Oncology, and Vice Chairman, Department of Obstetrics, Gynecology, and Reproductive Science, The Mount Sinai Medical Center, New York, NY
    Search for more papers by this author
    • Author disclosures: R. Marshall Austin, MD, PhD, has served as a consultant and/or speaker without accepting personal compensation for AutoCyte Inc., Cytyc Corporation, Digene Corporation, Morphometrix Technologies Inc., NeoPath, Inc., Neuromedical Sciences Inc., and Veracel Inc. J. Thomas Cox, MD, has consulted for Cytyc Corporation, Digene Corporation, 3M Pharmaceuticals, Inc., and Merck & Co., Inc., and is on the speaker's bureau of Cytyc Corporation, and 3M Pharmaceuticals, Inc. Jack Cuzick, PhD, is a consultant to Digene Corporation. Eduardo Franco, MPH, DrPH, has occasionally been invited by 3M Pharmaceuticals, Inc., GlaxoSmithKline, Digene Corporation, and F. Hoffmann-La Roche Ltd. to serve as a temporary consultant or visiting speaker. Walter Kinney, MD, has received research support from 3M Pharmaceuticals and serves on the speaker's bureau for Cytyc Corporation and Digene Corporation. Evan Myers, MD, MPH, has received research support from and is a consultant to Merck Research Laboratories. Ellen Sheets, MD, was appointed as a vice president of Cytyc Corporation in May 2002, following the ACS guideline workshop. Thomas C. Wright, Jr., MD, has received research support from Digene Corporation and Cytyc Corporation and is on the speaker's bureau of Cytyc Corporation and TriPath Imaging, Inc.


Abstract

An update to the American Cancer Society (ACS) guideline regarding screening for the early detection of cervical neoplasia and cancer, based on recommendations from a formal review and recent workshop, is presented. The new screening recommendations address when to begin screening, when screening may be discontinued, whether to screen women who have had a hysterectomy, appropriate screening intervals, and new screening technologies, including liquid-based cytology and HPV DNA testing.

Ancillary